[{"address1": "42127 Pleasant Forest Court", "city": "Ashburn", "state": "VA", "zip": "20148-7349", "country": "United States", "phone": "703 980 4182", "website": "https://quoinpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. The company was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. operates as a subsidiary of Skinvisible, Inc.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Dr. Michael  Myers Ph.D.", "age": 62, "title": "Co-Founder, CEO & Chairman", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 722550, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Denise  Carter", "age": 55, "title": "Co-Founder, COO & Director", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 593605, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gordon Bruce Dunn J.D.", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 433620, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.2901, "open": 0.295, "dayLow": 0.289, "dayHigh": 0.3048, "regularMarketPreviousClose": 0.2901, "regularMarketOpen": 0.295, "regularMarketDayLow": 0.289, "regularMarketDayHigh": 0.3048, "payoutRatio": 0.0, "beta": 1.591, "forwardPE": -0.24793388, "volume": 222587, "regularMarketVolume": 222587, "averageVolume": 5476450, "averageVolume10days": 392510, "averageDailyVolume10Day": 392510, "bid": 0.3, "ask": 0.3099, "bidSize": 1, "askSize": 1, "marketCap": 6175740, "fiftyTwoWeekLow": 0.27, "fiftyTwoWeekHigh": 1.57, "fiftyDayAverage": 0.36452, "twoHundredDayAverage": 0.566465, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -4957396, "profitMargins": 0.0, "floatShares": 19351092, "sharesOutstanding": 20585800, "sharesShort": 2678655, "sharesShortPriorMonth": 52821, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.32720003, "heldPercentInsiders": 0.065910004, "heldPercentInstitutions": 0.07512, "shortRatio": 0.26, "shortPercentOfFloat": 0.33220002, "impliedSharesOutstanding": 20585800, "bookValue": 1.029, "priceToBook": 0.29154518, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -8962472, "trailingEps": -1.91, "forwardEps": -1.21, "lastSplitFactor": "1:12", "lastSplitDate": 1689638400, "enterpriseToEbitda": 0.526, "52WeekChange": -0.6474736, "SandP52WeekChange": 0.086116076, "quoteType": "EQUITY", "currentPrice": 0.3, "targetHighPrice": 10.0, "targetLowPrice": 1.44, "targetMeanPrice": 4.48, "targetMedianPrice": 2.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 14056878, "totalCashPerShare": 0.683, "ebitda": -9428465, "totalDebt": 2923733, "quickRatio": 3.362, "currentRatio": 3.57, "debtToEquity": 31.764, "returnOnAssets": -0.42723, "returnOnEquity": -1.20555, "freeCashflow": -4275041, "operatingCashflow": -7857309, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "QNRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Quoin Pharmaceuticals, Ltd.", "longName": "Quoin Pharmaceuticals, Ltd.", "corporateActions": [], "postMarketTime": 1742594399, "regularMarketTime": 1742587200, "exchange": "NCM", "messageBoardId": "finmb_593010770", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "regularMarketChangePercent": 3.4126174, "regularMarketPrice": 0.3, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1470058200000, "postMarketChangePercent": -2.9, "postMarketPrice": 0.2913, "postMarketChange": -0.00870001, "regularMarketChange": 0.009900004, "regularMarketDayRange": "0.289 - 0.3048", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 5476450, "fiftyTwoWeekLowChange": 0.030000001, "fiftyTwoWeekLowChangePercent": 0.11111111, "fiftyTwoWeekRange": "0.27 - 1.57", "fiftyTwoWeekHighChange": -1.27, "fiftyTwoWeekHighChangePercent": -0.80891716, "fiftyTwoWeekChangePercent": -64.74736, "dividendDate": 1571788800, "earningsTimestamp": 1741865400, "earningsTimestampStart": 1746621000, "earningsTimestampEnd": 1747053000, "earningsCallTimestampStart": 1710419400, "earningsCallTimestampEnd": 1710419400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.91, "epsForward": -1.21, "epsCurrentYear": -0.5, "priceEpsCurrentYear": -0.6, "fiftyDayAverageChange": -0.06452, "fiftyDayAverageChangePercent": -0.17699988, "twoHundredDayAverageChange": -0.266465, "twoHundredDayAverageChangePercent": -0.47039977, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Cellect Biotechnology Ltd.", "nameChangeDate": "2025-03-20", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "displayName": "Quoin Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-03-22"}]